CVALF (Covalon Technologies) Research & Development: $0.91 Mil (TTM As of Mar. 2026)


CVALF Covalon Technologies Ltd CVALF
82 GF Score
Price $1.56
GF Value $1.54
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Covalon Technologies Research & Development?

Covalon Technologies CVALF -0.64% 82 Research & Development is $0.91 Mil as of Mar. 2026. GuruFocus rates CVALF with a GF Score™ of 82/100 and a GF Value™ of $1.54 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Covalon Technologies's Research & Development for the three months ended in Mar. 2026 was $0.25 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.91 Mil.

Covalon Technologies  (OTCPK:CVALF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Covalon Technologies Research & Development Related Terms

Covalon Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Covalon Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covalon Technologies Research & Development Chart

Covalon Technologies Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 1.02 1.04 1.18 0.95

Covalon Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.23 0.23 0.21 0.25
CVALF
82GF Score
Covalon Technologies Ltd CVALF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Covalon Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.91 Mil mean?
Covalon Technologies (CVALF) has a Research & Development of $0.91 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Covalon Technologies and its competitors.
Is Covalon Technologies' Research & Development too high?
Covalon Technologies' current Research & Development is $0.91 Mil. Overall, Covalon Technologies has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' Research & Development compare to ISRG and BDX?
Covalon Technologies' Research & Development of $0.91 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Covalon Technologies and its competitors. Covalon Technologies's current Research & Development is $0.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Fairly Valued. The stock's GF Value™ is $1.54, compared to a current price of $1.56 — trading 1.3% above its estimated fair value. The current Research & Development is $0.91 Mil. Covalon Technologies' overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current Research & Development is $0.91 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Covalon Technologies (CVALF) Overvalued in 2026?

Based on GuruFocus' analysis, Covalon Technologies stock appears to be overvalued. The current stock price of $1.56 is trading 1.3% above its estimated GF Value™ of $1.54. GuruFocus considers Covalon Technologies to be Fairly Valued.

Key valuation signals for CVALF:

  • Research & Development: $0.91 Mil
  • GF Value™: $1.54 vs. price of $1.56 (1.3% above fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Covalon Technologies Business Description

Other Exchanges COV:Canada
Address 1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
82GF Score

Get the complete analysis for CVALF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.56
Price
$1.54
GF Value